Simplex Trading
LTRN icon

Simplex Trading’s Lantern Pharma LTRN Stock Holding History

Simplex Trading’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$137 Sell
100
-200
-67% -$559 ﹤0.01% 8858
2025
Q4 		$909 Buy
+300
New +$1.12K ﹤0.01% 8050
2024
Q2 		– Sell
-1,100
Closed -$9K – 9372
2024
Q1 		$9K Buy
+1,100
New +$5.88K ﹤0.01% 7684
2022
Q4 		– Sell
-15,900
Closed -$76K – 9881
2022
Q3 		$76K Buy
15,900
+13,700
+623% +$73.6K ﹤0.01% 5888
2022
Q2 		$12K Hold
2,200
– – ﹤0.01% 8129
2022
Q1 		$15K Hold
2,200
– – ﹤0.01% 8527
2021
Q4 		$17K Buy
+2,200
New +$20.1K ﹤0.01% 8552

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Simplex Trading's LTRN Position: Q1 2026 in Review

Simplex Trading reduced its Lantern Pharma (LTRN) stake by 95% in Q1 2026, selling an estimated $6.01K and leaving 107 shares worth $146. The position accounts for ﹤0.01% of the portfolio, ranked #8855.

Simplex Trading first reported a position in LTRN in Q1 2022 and has held it in 9 quarters since. The position peaked at $25K in Q1 2024. 33 funds tracked by Wall St. Rank hold LTRN as of Q1 2026.

  • Simplex Trading held 107 shares of Lantern Pharma worth $146 as of Q1 2026.
  • Simplex Trading sold 2,150 Lantern Pharma shares in Q1 2026, an estimated $6.01K.
  • Lantern Pharma made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8855 holding.
  • Simplex Trading first reported a position in Lantern Pharma in Q1 2022 and has held it in 9 quarters since.
  • Simplex Trading's Lantern Pharma position peaked at $25K in Q1 2024.
  • 33 funds tracked by Wall St. Rank held Lantern Pharma as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.